semaglutide eyesight Eye Condition a 'Very Rare' Side Effect of Semaglutide, EMA Says GLP-1 Drugs Could Double Risk

Description

The European equivalent of the FDA launched an investigation based on concerns regarding the potential mental health side effects in July 2023 and have stated they expect to conclude their investigation by the end of November 2023

The short answer Mounjaro is the brand name for tirzepatide, a dual GIP/GLP-1 receptor agonist approved to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes when used with diet and exercise

Now you have injected 0.5 mg, double your intended dose

Evidence Suggesting a Potential Adverse Impact of GLP-1 Receptor Agonists on Erectile Function Despite increasing evidence supporting the beneficial effects of GLP-1 RAs on erectile function, a limited number of studies have raised concerns regarding potential adverse sexual outcomes